Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy

Author： Bolger Gordon Lapeyre Nicole Dansereau Nathalie Lagacé Lisette Berry Gerald Klosowski Katy Mewhort Tracy Liuzzi Michel

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.83, Iss.2, 2005-02, pp. : 198-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erratum: Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy

By Bolger Gordon Lapeyre Nicole Dansereau Nathalie Lagacé Lisette Berry Gerald Klosowski Katy Mewhort Tracy Liuzzi Michel

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 3, 2005-03 ,pp. : 319-319

NRC Research Press

Access to resources Recommend Favorite

Respiratory syncytial virus antiviral agents

By Prince G.A.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 6, 1999-06 ,pp. : 753-762

Informa Healthcare

Access to resources Recommend Favorite

An update on respiratory syncytial virus antiviral agents

By Prince G.A.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 2, 2001-02 ,pp. : 297-308

Informa Healthcare

Access to resources Recommend Favorite

The development of antiviral therapy and vaccines against respiratory syncytial virus and human parainfluenza virus type 3

By A J.E.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 4, 2001-08 ,pp. : 175-190

Adis International

Access to resources Recommend Favorite

Emerging drugs for respiratory syncytial virus infection

By Olszewska Wieslawa Openshaw Peter

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 207-217

Informa Healthcare

Access to resources Recommend Favorite